Cognitive Behavioural Therapy/Metacognitive Therapy for Low Self Esteem
Launched by UNIVERSITY OF OSLO · Mar 5, 2025
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of two types of therapy—Cognitive Behavioral Therapy (CBT) and Metacognitive Therapy (MCT)—on people who have low self-esteem. The goal is to understand how effective these therapies are in helping individuals feel better about themselves, and to learn more about the changes that happen during treatment. The trial will involve 20 participants who are 18 years or older and have low self-esteem, as indicated by their scores on a specific self-esteem questionnaire.
To participate in this study, individuals must agree to take part and cannot have certain mental health conditions, such as severe mood disorders or substance dependence. Participants will receive either CBT or MCT and will be monitored throughout the treatment to see how they respond and if the benefits last. This research is important because it aims to find better ways to help people improve their self-esteem, which can have a positive impact on their overall well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Signed written informed consent obtained prior to entry in the study.
- • 2. Scores below 15 on the Rosenberg Self-esteem Scale (RSE)
- • 3. 18 years or older.
- Exclusion Criteria:
- • 1. Psychosis
- • 2. Bipolar type 1
- • 3. Current suicide intent
- • 4. PTSD
- • 5. Cluster A or cluster B personality disorder
- • 6. Substance dependence
About University Of Oslo
The University of Oslo, a leading research institution in Norway, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration and ethical research practices, the university harnesses its extensive expertise in various fields, including medicine, health sciences, and biomedical research. The University of Oslo actively engages in clinical trials aimed at exploring new therapies and interventions, fostering a culture of scientific inquiry, and contributing to the global understanding of health and disease. Through its commitment to excellence and rigorous methodologies, the university seeks to translate research findings into tangible benefits for patients and society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oslo, , Norway
Patients applied
Trial Officials
Roger Hagen, Professor
Principal Investigator
University of Oslo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported